[Cellular and humoral indicators of the immunomodulating effect of levamisole in patients with lymphocytic leukemia].
D000276:Adjuvants, Immunologic; D000368:Aged; D001402:B-Lymphocytes / Q000276:immunology*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000276:immunology*; D007958:Leukocyte Count / Q000187:drug effects; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000276:immunology*
D000276:Adjuvants, Immunologic; D007136:Immunoglobulins; D007978:Levamisole
Kletochno-gumoral'nye pokazateli immunomoduliruiushchego vliianiia levamizola u bol'nykh khronicheskim limfoleĭkozom.